Tolvaptan has Liver Injury Risk Says FDA
Otsuka and FDA notified healthcare professionals of significant liver injury associated with the use of Samsca.
At Last a Drug for Genetic Kidney Disease
Researchers have known about polycystic kidney disease for more than a century. However, they have had trouble coming up with an effective treatment for this common disease. That is, until now.